Ryan H. Saadi - 27 Jun 2025 Form 4 Insider Report for Tevogen Bio Holdings Inc. (TVGN)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Kirti Desai, Attorney-in-Fact
Issuer symbol: TVGN
Transactions as of: 27 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 01 Jul 2025, 16:49:36 UTC
Previous filing: 09 Jun 2025
Next filing: 18 Aug 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Saadi Ryan H.	Chief Executive Officer, Director, 10%+ Owner	C/O TEVOGEN BIO HOLDINGS INC., 15 INDEPENDENCE BLVD, STE 210, WARREN	/s/ Kirti Desai, Attorney-in-Fact	01 Jul 2025	0002011728

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TVGN	Common Stock	Award	$0	+8,000,000	+6.8%	$0.000000	124,814,453	27 Jun 2025	Direct	F1
holding	TVGN	Common Stock						193,924	27 Jun 2025	By wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock under the Tevogen Bio Holdings Inc. 2024 Omnibus Incentive Plan, which will vest ratably in four equal annual installments commencing on June 27, 2032, provided that the reporting person remains in service with the Issuer at such dates.